Over the last 12 months, two Cassava Sciences Inc insiders purchased shares on the open market, about $641,000 in total, and none of them sold.
Barry Richard (CEO) made the biggest buy, worth around $414,000. Notably, at least one C-suite executive was among the buyers.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Anderson Robert Eugene Jr | Director | Buy | 8,600 | $2.90 | $25K | SEC |
| Nov 24, 2025 | Barry Richard | CEO | Buy | 150,000 | $2.76 | $414K | SEC |
| Nov 20, 2025 | Barry Richard | CEO | Buy | 73,385 | $2.75 | $202K | SEC |
| Oct 2, 2025 | Cook Robert Christopher | COO | Buy | 13,725 | $2.91 | $40K | SEC |
| Sep 23, 2025 | Barry Richard | CEO | Buy | 7,172 | $2.28 | $16K | SEC |
| Sep 22, 2025 | Barry Richard | CEO | Buy | 5,400 | $2.13 | $12K | SEC |
| Sep 22, 2025 | Barry Richard | CEO | Buy | 185,233 | $2.24 | $415K | SEC |
| Sep 22, 2025 | Barry Richard | CEO | Buy | 400 | $2.25 | $900 | SEC |
| Sep 22, 2025 | Barry Richard | CEO | Buy | 46,908 | $2.29 | $107K | SEC |
| Dec 3, 2024 | Kupiec James William | Executive Officer | Sell | 4,000 | $3.87 | $15K | SEC |
| Dec 3, 2024 | Schoen Eric | CFO | Sell | 2,000 | $3.82 | $8K | SEC |
| Dec 3, 2024 | Schoen Eric | CFO | Sell | 59,800 | $3.86 | $231K | SEC |
| Aug 24, 2023 | ROBERTSON SANFORD | Director | Buy | 30,000 | $17.45 | $524K | SEC |
| Aug 23, 2023 | Barry Richard | Director | Buy | 1,906 | $16.80 | $32K | SEC |
| Aug 23, 2023 | Barry Richard | Director | Buy | 16,571 | $16.65 | $276K | SEC |
In the last 12 months Cassava Sciences Inc insiders made open-market purchases worth about $641,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SAVA was filed on 2025-11-25.
No congressional trades in SAVA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).